1 – 20 of 62
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor
- The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer
- Heme detoxification by heme oxygenase-1 reinstates proliferative and immune balances upon genotoxic tissue injury
- 2018
- SATB1 in Malignant T Cells
- The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer
- A panel of biomarkers for diagnosis of prostate cancer using urine samples
- 2017
- HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells
- ISA-2011B, a phosphatidylinositol 4-phosphate 5-kinase a inhibitor, impairs CD28-dependent costimulatory and pro-inflammatory signals in human T lymphocytes
- Androgen dependent mechanisms of pro-angiogenic networks in placental and tumor development
- Heterodimers of photoreceptor-specific nuclear receptor (PNR/NR2E3) and peroxisome proliferator-activated receptor-γ (PPARγ) are disrupted by retinal disease-associated mutations
- Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome
- Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells
- 2016
- The expression of IL-21 is promoted by MEKK4 in malignant T cells and associated with increased progression risk in cutaneous T-cell lymphoma
- Cyclin A1 and P450 aromatase promote metastatic homing and growth of stem-like prostate cancer cells in the bone marrow.
- Vitronectin: a promising breast cancer serum biomarker for early diagnosis of breast cancer in patients.
- Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells
- STAT5 induces miR-21 expression in cutaneous T cell lymphoma
- Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
- Hematopoietic and Mesenchymal Stem Cells in Biomedical and Clinical Applications
- 2015
- Heme oxygenase-1 in macrophages controls prostate cancer progression.